PER 34.1% 8.9¢ percheron therapeutics limited

DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-89

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    CR unlikely with almost $3 million in cash thats enough for minimum 1 year , Phase 2 results is around the corner if positive then cash will come through a big partnership who will pay upfront payments north of US$40 million or buying the whole company which is much cheaper than to pay royalties and big milestones .STRONG BUY AGGRESSIVE, i think this one will do better than Biotron (BIT) did last year from 0.02 to around 40c .DMD is much hotter market than HIV and Hepatitis for which there is aready many marketed treatments available .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
-0.046(34.1%)
Mkt cap ! $80.23M
Open High Low Value Volume
8.7¢ 9.0¢ 8.6¢ $2.082M 23.82M

Buyers (Bids)

No. Vol. Price($)
5 250808 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 312804 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.